Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Practice

E. coli — sporadic case or an outbreak?

Erica Weir and Karen Hay
CMAJ June 06, 2006 174 (12) 1711; DOI: https://doi.org/10.1503/cmaj.060053
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Hay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Background and epidemiology: One of the many unfortunate consequences of the Walkerton tainted-water tragedy has been a lingering association of Escherichia coli O157:H7 with large-scale outbreaks. Lost somewhere among the lessons learned is an appreciation that E. coli can be much more subtle.

Figure

Figure. Escherichia coli in a section of intestine from an 8-month-old child with chronic diarrhea. Photo by: CDC

Most incidents of E. coli O157:H7 infection reported to and investigated by public health personnel are isolated and sporadic. The province of Ontario receives some 20– 50 reports monthly of verotoxigenic E. coli (VTEC) infections. VTEC cases come to the attention of public health when they fall on the severe side of the infection's wide clinical spectrum and involve infants or elderly people admitted to hospital with serious outcomes such as hemolytic uremic syndrome (HUS), thrombotic thrombocytopenia purpura or hemorrhagic colitis. Cases of milder forms of infection often fall below the public-health radar.

Public health officials are responsible to ascertain whether each case reported is isolated, with a limited setting and source, or a harbinger of wider exposure and continued public-health risk. Since the data available for these rapid assessments are often imperfect and incomplete, it is important for physicians, public health officials and laboratories to work together to maximize the possible harvest from the available information.

Epidemiological investigations are complicated by the many potential sources of exposure to virulent strains of E. coli. The route of exposure is invariably ingestion, by means of any number of vehicles (food, water, dirty hands) contaminated with animal or human fecal matter. Undercooked ground beef, unpasteurized milk or cider, salami, alfalfa sprouts, lettuce and contaminated water are notorious culprits,1 but virtually any exposure to unhygienic food practices or livestock, such as play around manure or attendance at a petting zoo, carries some potential for transmission.2 The infectious dose for E. coli O157:H7 is low (about 100 organisms); person-to-person transmission is common.

Clinical management: The spectrum of illness caused by E. coli O157:H7 ranges from mild nonbloody diarrhea to serious bloody diarrhea with severe abdominal cramping. Fever is typically either low-grade or absent, which can help the clinician to distinguish VTEC infections from those caused by other enteric pathogens. The incubation period averages about 4 days, but ranges from 1 to 10 days. Adults typically shed the bacteria for about a week after infection; young children, for up to 3 weeks. Treatment is, for the most part, supportive. The bulk of the existing evidence suggests that antibiotic treatment is not indicated and in some cases may increase the risk of HUS.3

Because enteric disease may be caused by bacteria, viruses or parasites, physicians should test patients with diarrheal illness for all 3. Routine bacterial examination of stool specimens includes tests for Salmonella, Shigella, Campylobacter, Yersinia and E. coli O157. Strains of E. coli O157 are differentiated by serotyping and molecular methods using pulse-field gel electrophoresis (PFGE).1

The National Laboratory for Enteric Pathogens maintains passive surveillance on all confirmed cases and provides information on the prevalence of strains of E. coli across Canada. The coincidence of uncommon strains among epidemiologically linked cases may indicate a common source of exposure. Identification of the same strain in associated food, water or environmental samples can establish the source, but negative test results do not automatically rule these out as infective sources because of the multitude of factors that can interfere with accurate sampling.

Prevention and control: Preventing this infection is difficult because the pathogen is ubiquitous. Prevention efforts focus on food safety, personal hygiene and the rapid identification of active cases. All suspected and confirmed cases should be reported to the local medical officer of health. People with suspected or confirmed infection who interact with vulnerable populations (e.g., children) or who handle food should refrain from these occupational activities until 2 stool samples have tested negative for E. coli.

REFERENCES

  1. 1.↵
    Woodward DL, Clark C, Caldeira R, et al. Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada. Can J Infect Dis 2002;13:321-30.
    OpenUrlPubMed
  2. 2.↵
    Centers for Disease Control and Prevention. Outbreaks of Escherichia coli 0157:H7 associated with petting zoos — North Carolina, Florida, and Arizona, 2004 and 2005. MMWR 2005;54(50);1277-80.
  3. 3.↵
    Tarr P, Gordon C, Chandler W. Shiga-toxin–producing Escherichia coli and haemolytic uraemic syndrome [review]. Lancet 2005;365:1073-86.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 174 (12)
CMAJ
Vol. 174, Issue 12
6 Jun 2006
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
E. coli — sporadic case or an outbreak?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
E. coli — sporadic case or an outbreak?
Erica Weir, Karen Hay
CMAJ Jun 2006, 174 (12) 1711; DOI: 10.1503/cmaj.060053

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
E. coli — sporadic case or an outbreak?
Erica Weir, Karen Hay
CMAJ Jun 2006, 174 (12) 1711; DOI: 10.1503/cmaj.060053
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • REFERENCES
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Dans ce numéro
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • SARS-CoV-2 vaccination in pregnancy
  • Infantile perianal pyramidal protrusion
  • Topical nonsteroidal anti-inflammatory drugs
Show more Practice

Similar Articles

Collections

  • Topics
    • Infectious diseases
    • Public health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire